ASCO Guideline Update on VTE Prophylaxis and Treatment in Patients with Cancer
The American Society of Clinical Oncology (ASCO) has been developing guidelines on cancer-associated thrombosis (CAT)...
Guidelines and Tools
Summary ESMO Clinical Practice Guideline for the management of venous thromboembolism in cancer patients
Venous thromboembolism (VTE) is the second cause of death in people with cancer, after cancer itself. Cancer and VTE...
Tools to raise thrombosis awareness in patients with cancer: a lesson from the EMPOWER study
Cancer-associated thrombosis (CAT) is the most frequent cause of death in patients with cancer after cancer itself . In...
American Society of Hematology Guidelines for Management of Cancer-Associated Thrombosis
Introduction The risk of venous thromboembolism (VTE) is substantially increased in patients with cancer especially...
The European Independent Foundation in Angiology/Vascular: Guidance for patient management during the COVID-19 emergency
The European Independent Foundation in Angiology/Vascular Medicine is a non-profit, scientific foundation dedicated to...
Platelet Cut-Off for Anticoagulant Therapy in Thrombocytopenic Patients with Blood Cancer and Venous Thromboembolism
Venous thromboembolism (VTE) is a recurrent risk factor in cancer patients. In particular, patients with hematologic...
Making cancer-related complications and comorbidities an EU health priority: a joint statement from the European Thrombosis and Haemostasis Alliance (ETHA)
Cancer represents the second most important cause of death and morbidity in Europe, with more than 3.7 million new...
Venous thromboembolism in patients with solid tumors: the Italian Association of Medical Oncology (AIOM) guidelines 2019
The latest guidelines for venous thromboembolism in patients with solid tumors from the Italian Association of Medical...
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
The American Society of Clinical Oncology just published the new recommendations regarding VTE prophylaxis and...
Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy
Approximately 4% of cancer patients have non-valvular atrial fibrillation (NVAF) and require anticoagulation for...